GB202108176D0 - Vector - Google Patents
VectorInfo
- Publication number
- GB202108176D0 GB202108176D0 GBGB2108176.5A GB202108176A GB202108176D0 GB 202108176 D0 GB202108176 D0 GB 202108176D0 GB 202108176 A GB202108176 A GB 202108176A GB 202108176 D0 GB202108176 D0 GB 202108176D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2108176.5A GB202108176D0 (en) | 2021-06-08 | 2021-06-08 | Vector |
JP2023575790A JP2024520797A (en) | 2021-06-08 | 2022-06-08 | Lentiviral Vectors |
MX2023014228A MX2023014228A (en) | 2021-06-08 | 2022-06-08 | Lentiviral vector. |
BR112023025408A BR112023025408A2 (en) | 2021-06-08 | 2022-06-08 | CLOSED LINEAR DNA VECTOR SUITABLE FOR USE AS A LENTIVIRAL TRANSFER VECTOR, AND, METHOD FOR IMPROVING THE INFECTIOUS TITLE OF LENTIVIRAL PARTICLES WHEN THE TRANSFER VECTOR IS A CLOSED LINEAR DNA VECTOR |
AU2022289260A AU2022289260A1 (en) | 2021-06-08 | 2022-06-08 | Lentiviral vector |
EP22730967.1A EP4352238A1 (en) | 2021-06-08 | 2022-06-08 | Lentiviral vector |
CA3222751A CA3222751A1 (en) | 2021-06-08 | 2022-06-08 | Lentiviral vector |
IL308705A IL308705A (en) | 2021-06-08 | 2022-06-08 | Lentiviral vector |
PCT/GB2022/051437 WO2022258967A1 (en) | 2021-06-08 | 2022-06-08 | Lentiviral vector |
KR1020237042463A KR20240024807A (en) | 2021-06-08 | 2022-06-08 | Lentivirus vectors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2108176.5A GB202108176D0 (en) | 2021-06-08 | 2021-06-08 | Vector |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202108176D0 true GB202108176D0 (en) | 2021-07-21 |
Family
ID=76838732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2108176.5A Ceased GB202108176D0 (en) | 2021-06-08 | 2021-06-08 | Vector |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202108176D0 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0770140A1 (en) | 1994-07-13 | 1997-05-02 | Aventis Pharma S.A. | Nucleic acid containing composition, preparation and uses of same |
US5686279A (en) | 1993-06-11 | 1997-11-11 | Cell Genesys, Inc. | Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
WO2010086626A1 (en) | 2009-01-30 | 2010-08-05 | Touchlight Genetics Limited | Production of closed linear dna |
WO2012017210A1 (en) | 2010-08-04 | 2012-02-09 | Touchlight Genetics Limited | Production of closed linear dna using a palindromic sequence |
WO2016132129A1 (en) | 2015-02-17 | 2016-08-25 | Touchlight Genetics Limited | Method of dna synthesis |
WO2018033730A1 (en) | 2016-08-16 | 2018-02-22 | Touchlight IP Limited | Closed linear dna production |
-
2021
- 2021-06-08 GB GBGB2108176.5A patent/GB202108176D0/en not_active Ceased
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5686279A (en) | 1993-06-11 | 1997-11-11 | Cell Genesys, Inc. | Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
EP0770140A1 (en) | 1994-07-13 | 1997-05-02 | Aventis Pharma S.A. | Nucleic acid containing composition, preparation and uses of same |
US6013240A (en) | 1994-07-13 | 2000-01-11 | Rhone-Poulenc Rorer Sa | Nucleic acid containing composition, preparation and uses of same |
WO2010086626A1 (en) | 2009-01-30 | 2010-08-05 | Touchlight Genetics Limited | Production of closed linear dna |
WO2012017210A1 (en) | 2010-08-04 | 2012-02-09 | Touchlight Genetics Limited | Production of closed linear dna using a palindromic sequence |
WO2016132129A1 (en) | 2015-02-17 | 2016-08-25 | Touchlight Genetics Limited | Method of dna synthesis |
WO2018033730A1 (en) | 2016-08-16 | 2018-02-22 | Touchlight IP Limited | Closed linear dna production |
Non-Patent Citations (15)
Title |
---|
"Culture of Animal Cells: A Manual of Basic Technique", 2000, WILEY-LISPS, article "Serum-Free Media", pages: 89 - 104,105-120 |
DULL ET AL.: "A third-generation lentivirus vector with a conditional packaging system", JOURNAL OF VIROLOGY, vol. 72, no. 11, 1998, pages 8463 - 8471, XP055715204, DOI: 10.1128/JVI.72.11.8463-8471.1998 |
FARSON ET AL.: "A new-generation stable inducible packaging cell line for lentiviral vectors", HUM GENE THER, vol. 12, no. 8, 2001, pages 981 - 97, XP002263325, DOI: 10.1089/104303401750195935 |
FELDMAN ET AL.: "The Nav channel bench series: plasmid preparation", METHODS X., vol. 1, 2014, pages 6 - 11 |
GODBEY W. T. ET AL., J. CONTROL RELEASE, vol. 60, 1999, pages 149160 |
GOLDING, M.MANN, M.: "A bidirectional promoter architecture enhances lentiviral transgenesis in embryonic and extraembryonic stem cells", GENE THERAPY, vol. 18, 2011, pages 817 - 826, XP055357962, Retrieved from the Internet <URL:https://doi.org/10.1038/gt.2011.23> DOI: 10.1038/gt.2011.26 |
MCMAHON ET AL., NIH PUBLIC ACCESS, vol. 27, 2015, pages 320 - 31 |
MERTEN ET AL.: "Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application.", HUMAN GENE THERAPY, vol. 22, no. 3, 2011, pages 343 - 356, XP055023182, Retrieved from the Internet <URL:http://doi.org/10.1089/hum.2010.060> DOI: 10.1089/hum.2010.060 |
MERTEN, O. W.HEBBEN, M.BOVOLENTA, C.: "Production of lentiviral vectors. Mol. Ther.", METHODS CLIN. DEV., vol. 3, 2016, pages 16017 |
MERTENHEBBENBOVOLENTA, MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, vol. 3, 2016, pages 16017 |
ORY ET AL.: "A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes", PNAS USA, vol. 93, 1996, pages 11400 - 11406, XP002030515, DOI: 10.1073/pnas.93.21.11400 |
SANBER ET AL.: "Construction of stable packaging cell lines for clinical lentiviral vector production", SCI REP, vol. 5, 2015, pages 9021, XP055491335, DOI: 10.1038/srep09021 |
SCHWEIZERMERTEN, CURRENT GENE THERAPY, vol. 10, no. 6, 2010, pages 474 - 486 |
SHAIMARDANOVA ET AL.: "Production and Application of Multicistronic Constructs for Various Human Disease Therapies", PHARMACEUTICS, vol. 11, no. 11, 2019, pages 580, XP055776188, DOI: 10.3390/pharmaceutics11110580 |
ZUFFEREY ET AL.: "Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo", NATURE BIOTECHNOLOGY, vol. 15, 1997, pages 871 - 875, XP002056816, DOI: 10.1038/nbt0997-871 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA204428S (en) | Case | |
CA207972S (en) | Case | |
GB201800903D0 (en) | Vectors | |
GB202010009D0 (en) | Vector | |
GB2590774B (en) | Vector | |
GB201715052D0 (en) | Vectors | |
GB202019108D0 (en) | Vector | |
IL288419A (en) | Recombinant herpesvirales vector | |
CA203786S (en) | Case | |
GB201717524D0 (en) | Vectors | |
EP3938518A4 (en) | Expression vector | |
GB201807945D0 (en) | Vector production | |
IL274178A (en) | Vector add-with-carry instruction | |
CA203793S (en) | Case | |
CA203242S (en) | Case | |
GB2597708B (en) | Vector processing | |
GB201913974D0 (en) | Vector | |
GB202117741D0 (en) | Feature vector feasibilty estimation | |
GB202014751D0 (en) | Targeting vector | |
GB201705927D0 (en) | Vector | |
IL274278A (en) | Vectors | |
GB202108176D0 (en) | Vector | |
GB202019286D0 (en) | Expresison vector | |
GB202009420D0 (en) | Vector | |
EP3704244C0 (en) | Vector construct |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |